• <blockquote id="sqo4s"></blockquote>
  • <rt id="sqo4s"><kbd id="sqo4s"></kbd></rt>
  • <td id="sqo4s"></td>
    Food & Food Contact Materials
    CIRS Group
    Chemicals
    Food
    Cosmetic
    Medical Devices
    Agrochemicals
    Biocide
    Carbon Neutrality
    Testing
    Search

    US New Dietary Ingredient (NDI) Updated: Which New Substances Can be Used in Dietary Supplements?

    from CIRS by

    The U.S. New Dietary Ingredient (NDI) database was updated on May 8, with a total of 27 substances having their status updated. 

    It should be noted that there is a lag in the NDI database updates. The latest FDA response times in this update report are all earlier than December 18, 2025. Currently, the actual number of completed NDI notifications is actually greater than the data currently published on the official website. CIRS Group will continue to pay close attention to subsequent updates on the FDA official website.

    Status of the 27 substances updated

    Since NDIN 1409, a total of 27 notifications have been submitted, of which 13 have been successfully notified, and 14 have not, with a pass rate of less than 50%. The notifications that did not pass include 12 objection letters (involving five cases of insufficient identity information, two cases of insufficient safety evidence, and five cases of both being insufficient) and two letters regarding other regulatory issues that do not meet the definition of dietary ingredients.

    For specific information on the NDIN numbers, names, companies, and FDA responses of the 27 substances, see the table below. 

    NDIN Number

    NDI Name

    Company

    Response Time

    FDA Response

    1409

    Mangosteen Peel Extract

    Fytexia

    2025/8/7

    Notified

    1410

    Emmer Wheat

    KMF Co., Ltd.

    2025/7/16

    Non-notified: Insufficient Identity Information

    1411

    Tamarind Seed Polysaccharide

    DEVINTEC SAGL

    2025/8/12

    Notified

    1412

    Porcine kidney protein extract with Diamine Oxidase (DAO)

    Body Nostrum LLC

    2025/7/29

    Non-notified: Insufficient Identity Information

    1413

    Diosmin / Micronized Diosmin

    Bordas S.A.

    2025/8/28

    Notified

    1414

    Latilactobacillus curvatus LB-P9

    LISCure Biosciences Inc.

    2025/9/3

    Notified

    1415

    T-ChOS (proprietary name by Genis hf.)

    Genis hf.

    2025/9/10

    Notified

    1416

    Benesomno™

    Nutra-it Inc.

    2025/9/9

    Notified

    1417

    Amanita muscaria mushroom extract (AME-1)

    Psyched Wellness

    2025/9/18

    Non-notified: Insufficient Identity Information & Safety Evidence

    1418

    Concentrated Nutriterra® Omega-3

    Nuseed Nutritional US Inc.

    2025/9/19

    Does not meet the definition of dietary ingredients

    1419

    Vernonanthura nudiflora extract

    OSigma Cell & Genetics

    2025/9/19

    Non-notified: Insufficient Identity Information & Safety Evidence

    1420

    β-Nicotinamide Riboside Citrate

    Shenzhen Nuojiayi Technology CO., Ltd

    2025/9/23

    Notified

    1421

    Jatropha macrantha (commonly known as Huanarpo Macho) Powder

    Toro Naturals LLC

    2025/9/22

    Non-notified: Insufficient Identity Information

    1422

    Heri-Mycelium HE12

    NEW BELLUS ENTERPRISES CO., LTD (Taiwan, China)

    2025/9/26

    Notified

    1423

    Lactobacillus farraginis

    epikur international AG

    2025/9/25

    Does not meet the definition of dietary ingredients

    1424

    Muno-IgY

    IGY Immune Technologies and Life Sciences, Inc.

    2025/9/26

    Notified

    1425

    Cannabis Sativa L. Essential Oil

    Mondays Foods, LLC

    2025/11/21

    Non-notified: Insufficient Identity Information & Safety Evidence

    1426

    NP-14D

    Dave's Tinctures

    2025/11/28

    Non-notified: Insufficient Identity Information & Safety Evidence

    1427

    CHAGADVANCE™ Chaga extract

    SEPPIC S.A.

    2025/9/30

    Non-notified: Insufficient Identity Information

    1428

    Astragalus extract mixture (HT042) aka Grow HT042

    NEUMED, Inc.

    2025/9/30

    Notified

    1429

    Cell-wall Broken Ganoderma Lucidum Spore Powder

    Fujian Xianzhilou Biological Science and Technology Co., Ltd.

    2025/9/30

    Non-notified: Insufficient Identity Information

    1430

    Spirulysat

    ALGOSOURCE

    2025/12/5

    Notified

    1431

    First Phytoplankton®

    Phytoplankton Solutions Inc.

    2025/12/4

    Non-notified: Insufficient Safety Evidence

    1432

    Bovine Gelatin Tannate powder

    California Greens

    2025/11/28

    Non-notified: Insufficient Identity Information & Safety Evidence

    1433

    Phaeodactylum tricornutum extract powder

    Microalgae Ask Us

    2025/12/3

    Non-notified: Insufficient Safety Evidence

    1434

    Calcium L-5-Methyltetrahydrofolate (L-5-MTHF-Ca)

    Wuxi Taxus Pharmaceutical Co., Ltd.

    2025/12/5

    Notified

    1435

    IMG-1

    Imagin Pharma

    2025/12/18

    Notified

    CIRS Group would like to remind that the U.S. NDI notification allows the use of private data, but also requires more detailed and comprehensive data than GRAS notices. During the preparation of the application, companies should carefully understand the data requirements of the NDI notification, systematically organize the substance identity information, production processes, and safety data, ensuring that the information is complete and traceable to meet the FDA’s review requirements.

    To learn more details on how to understand the FDA’s response to NDI, please read our previous article - US NDI Notification: A Step-by-Step Guide to Understanding FDA Letters.

    About CIRS

    Established in 2007, the CIRS Group is a leading product safety and regulatory consulting firm. CIRS has branch offices in the Republic of Ireland, South Korea, the United States, the United Kingdom, Japan and China. CIRS Group utilizes its technical expertise, various resources, and international network to provide one-stop compliance services from regulatory compliance, laboratory testing, R&D to data services across multiple industries. This includes chemicals, cosmetics, food and food beverages, feed and pet food, medical devices, agrochemical products, disinfectants, and consumer goods. It helps clients gain a competitive advantage by reducing business risks associated with regulatory affairs.

    The vast majority of team members in CIRS Food Business Division have over 10 years of professional experience in food compliance, with more than 80% hold Master’s or Doctoral degrees in food-related disciplines. The CIRS toxicology expert team consists 24 Chinese Certified Toxicologists (DCST), 2 American Board Certified Toxicologists (DABT), and 2 European Registered Toxicologists (ERT). CIRS has provided one-stop food compliance services to over 1,000 domestic and international food and related enterprises. Leveraging its technical expertise, diverse resources, and global network, the CIRS Food Business Division offers global food compliance services, including:

    • Health food registration and filing in China;
    • Application for “Three New Foods” in China;
    • U.S. GRAS, NDI, and CAP notifications;
    • EU Novel Food, food additives, and food enzymes applications; and
    • Application for new feed ingredients and feed additives in China, the U.S., and the EU.

    If you need any assistance or have any questions, please get in touch with us via service@cirs-group.com.

      

    We have launched a LinkedIn newsletter to keep you up to date on the latest developments across the chemical industry including food and FCMs and personal and home care.

    Contact Us
    +353 1 477 3710 (EU)
    +44 20 3239 9430 (UK)
    +1 703 520 1420 (USA)
    +86 571 8720 6574 (CN)
    +82 2 6347 8816 (KR)
    +81 070-9365-8022 (JP)
  • <blockquote id="sqo4s"></blockquote>
  • <rt id="sqo4s"><kbd id="sqo4s"></kbd></rt>
  • <td id="sqo4s"></td>
    丝瓜视频